Pharmaceutical Dissolution Testing Services Market is expected to reach USD 1.53 Billion at a CAGR of 8.3% by 2033

Pharmaceutical Dissolution Testing Services Market

The Pharmaceutical Dissolution Testing Services Market is poised for significant growth, with a projected market value of USD 1.53 billion by 2033. This surge represents a substantial increase from the USD 693.12 million market value in 2023, reflecting a robust Compound Annual Growth Rate (CAGR) of 8.3%.

For the physical assessment of solid dosage forms, such as tablets, capsules, ointments, and creams, dissolution testing is required. The simplest type of testing measures the solubility or rate of dissolving a medication tablet. Dissolution testing can be performed to assess the release rates of a drug material under various situations and to provide details regarding the effectiveness of in vivo performance in Absorption, Distribution, Metabolism, And Excretion (ADME) and bioavailability studies.

Dissolution testing provides information on how quickly or slowly certain drugs are absorbed into various body parts and, subsequently, how much they dissolve after administration. This enables businesses to assess whether a drug will function effectively after it enters a patient’s system and whether any negative effects brought on by slower absorption rates would occur.

Key Takeaways from the Pharmaceutical Dissolution Testing Services Market Study

• By dosage form, the tablets dosage form segment is expected to dominate the global industry in 2023 and account for the maximum share of more than 65% of the overall revenue.
• By dissolution apparatus, the paddle segment is expected to dominate the industry and account for the largest revenue share of more than 70% in 2023.
• By method, the in-vitro method segment is expected to dominate the global market in 2023 and account for the largest share of more than 58% of the overall revenue.
• North America is expected to dominate the global industry in 2023 and account for the maximum share of more than 50% of the overall revenue.
• Asia Pacific is expected to possess 33% market share for pharmaceutical dissolution testing services market in Asia Pacific.

“Pharmaceutical dissolution testing requires specialized staff to run the assays and prepare regulatory filings. This factor has greatly increased the demand for professional teams to handle pharmaceutical dissolution testing, which is predicted to have a favorable effect on the industry.” comments a Future Market Insights analyst.

Pharmaceutical Dissolution Testing Services Market Competitive Landscape

Some of the prominent players in the global pharmaceutical dissolution testing services market include Intertek Group Plc, Avivia BV, Almac Group, Agilent Technologies, Inc, Catalent, Inc, Thermofisher Scientific Inc, Cambrex, Charles River Laboratories, Boston Analytical, Pace Analytical Life Sciences, SOTAX, AMRI, SGS SA

• In August 2022, Almac, AstraZeneca CDx have entered into a partnership that is branching out to new disease areas, drawing on NGS, qPCR. The company is focusing on investing in research and development to assess and understand nature of diseases and manufacture medication for the same.
• Avivia, a key player in pharmaceutical dissolution testing services market is focusing on offering full product development services to generic drug companies and specialty pharma focused on the development of new improved versions (value-added generics or generic plus) of established drug products.

A Full Report Overview

Drug Dissolution Analysis is a critical aspect of drug development and manufacturing, which involves the assessment of the rate at which a drug substance dissolves in a specific medium.

Key Segments Profiled in the Pharmaceutical Dissolution Testing Services Market Survey

By Method:

• In Vitro
• In Vivo

By Dosage Form:

• Capsules
• Tablets
• Others

By Dissolution Apparatus:

• Basket
• Paddle
• Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube